Gösterilen 1 - 2 sonuçlar arası kayıtlar. 2 sonuç. Aranan kelime 'Srivandana Akshintala (16610490)', Sorgu süresi: 0.01s Sonuçları Daraltın
  1. 1
    Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

    Supplementary Table S5 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma Yazar: Srivandana Akshintala (16610490)

    Baskı/Yayın Bilgisi 2025
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

    Supplementary Dataset S1 from Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma Yazar: Srivandana Akshintala (16610490)

    Baskı/Yayın Bilgisi 2025
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: